Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1996 May 25;312(7042):1347–1348. doi: 10.1136/bmj.312.7042.1347

Screening asymptomatic people at high risk for hepatitis C. The case for.

C A Seymour 1
PMCID: PMC2351003  PMID: 8646052

Full text

PDF
1347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J. Epidemiology of hepatitis C in the West. Semin Liver Dis. 1995 Feb;15(1):5–14. doi: 10.1055/s-2007-1007259. [DOI] [PubMed] [Google Scholar]
  2. Bresters D., Mauser-Bunschoten E. P., Reesink H. W., Roosendaal G., van der Poel C. L., Chamuleau R. A., Jansen P. L., Weegink C. J., Cuypers H. T., Lelie P. N. Sexual transmission of hepatitis C virus. Lancet. 1993 Jul 24;342(8865):210–211. doi: 10.1016/0140-6736(93)92300-i. [DOI] [PubMed] [Google Scholar]
  3. Bruno S., Rossi S., Petroni M. L., Villa E., Zuin M., Podda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ. 1994 Mar 12;308(6930):697–697. doi: 10.1136/bmj.308.6930.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cuckle H. S., Richardson G. A., Sheldon T. A., Quirke P. Cost effectiveness of antenatal screening for cystic fibrosis. BMJ. 1995 Dec 2;311(7018):1460–1464. doi: 10.1136/bmj.311.7018.1460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goodrick M. J., Gray S. F., Rouse A. M., Waters A. J., Anderson N. A. Hepatitis C (HCV)-positive blood donors in south-west England: a case control study. Transfus Med. 1994 Jun;4(2):113–119. doi: 10.1111/j.1365-3148.1994.tb00251.x. [DOI] [PubMed] [Google Scholar]
  6. Moradpour D., Wands J. R. Understanding hepatitis B virus infection. N Engl J Med. 1995 Apr 20;332(16):1092–1093. doi: 10.1056/NEJM199504203321610. [DOI] [PubMed] [Google Scholar]
  7. Saracco G., Rosina F., Abate M. L., Chiandussi L., Gallo V., Cerutti E., Di Napoli A., Solinas A., Deplano A., Tocco A. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. Hepatology. 1993 Dec;18(6):1300–1305. [PubMed] [Google Scholar]
  8. Terrault N., Wright T. Interferon and hepatitis C virus infection. N Engl J Med. 1995 Jun 1;332(22):1509–1511. doi: 10.1056/NEJM199506013322211. [DOI] [PubMed] [Google Scholar]
  9. Tinè F., Magrin S., Craxì A., Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol. 1991 Sep;13(2):192–199. doi: 10.1016/0168-8278(91)90814-r. [DOI] [PubMed] [Google Scholar]
  10. Uyttendaele S., Claeys H., Mertens W., Verhaert H., Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang. 1994;66(2):122–129. doi: 10.1111/j.1423-0410.1994.tb00293.x. [DOI] [PubMed] [Google Scholar]
  11. Watson J. P., Brind A. M., Chapman C. E., Bates C. L., Gould F. K., Johnson S. J., Burt A. D., Ferguson J., Simmonds P., Bassendine M. F. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut. 1996 Feb;38(2):269–276. doi: 10.1136/gut.38.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Zaaijer H. L., Cuypers H. T., Reesink H. W., Winkel I. N., Gerken G., Lelie P. N. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993 Mar 20;341(8847):722–724. doi: 10.1016/0140-6736(93)90488-3. [DOI] [PubMed] [Google Scholar]
  13. van der Poel C. L., Cuypers H. T., Reesink H. W. Hepatitis C virus six years on. Lancet. 1994 Nov 26;344(8935):1475–1479. doi: 10.1016/s0140-6736(94)90293-3. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES